Medically Eligible Women Who Do Not Use HAART: The Importance of Abuse, Drug Use, and Race
Mardge H. Cohen, MD,
Judith A. Cook, PhD,
Dennis Grey, BA,
Mary Young, MD,
Lawrence H. Hanau, MD,
Phyllis Tien, MD,
Alexandra M. Levine, MD and
Tracey E. Wilson, PhD
Mardge H. Cohen is with the CORE Center, Cook County Hospital, Cook County Bureau of Health Services, Chicago, Ill. Judith A. Cook and Dennis Grey are with the Department of Psychiatry, University of Illinois, Chicago. Mary Young is with the Department of Medicine, Georgetown University Medical Center, Washington, DC. Lawrence H. Hanau is with the Department of Medicine, Montefiore Medical Center, Bronx, NY. Phyllis Tien is with the Department of Medicine, University of California, San Francisco, and San Francisco Department of Veterans Affairs. Alexandra M. Levine is with the Division of Hematology, Keck School of Medicine, University of Southern California, Los Angeles. Tracey E. Wilson is with the Department of Preventive Medicine and Community Health, SUNY Downstate Medical Center, Brooklyn, NY.
Correspondence: Requests for reprints should be sent to Mardge H. Cohen, MD, 2020 W Harrison, Chicago, IL 60612 (e-mail: mcohen{at}corecenter.org).
Objectives. We investigated the prevalence and characteristicsof HIV-positive women who do not report highly active antiretroviraltherapy (HAART) use.
Methods. We analyzed HAART use among 1165 HIV-positive participantsin the Womens Interagency HIV Study.
Results. Between October 1, 2000, and March 31, 2001, 254 womenwith clinical indications for HAART reported not using it, 635reported HAART use, and 276 had no clinical indications. Inmultivariate analysis, using crack/cocaine/heroin and a historyof abuse decreased the likelihood of using HAART, whereas beingWhite increased it.
Conclusions. One of 4 women for whom HAART was indicated reportednot using HAART. Childhood sexual abuse prevention, more intensiveabuse treatment, and continuing drug treatment may enhance HIVdisease treatment of women.
Related articles in AJPH:
HIV and Women: When Words Speak Louder Than Actions
L. R. Metsch, C. Bell, M. Pereyra, G. Cardenas, T. Sullivan, A. Rodriguez, L. Gooden, N. Khoury, T. Kuper, T. Brewer, et al. Hospitalized HIV-Infected Patients in the Era of Highly Active Antiretroviral Therapy
Am J Public Health,
June 1, 2009;
99(6):
1045 - 1049.
[Abstract][Full Text][PDF]
P. E. Stevens and E. Hildebrandt Pill Taking From the Perspective of HIV-Infected Women Who Are Vulnerable to Antiretroviral Treatment Failure
Qual Health Res,
May 1, 2009;
19(5):
593 - 604.
[Abstract][PDF]
K. Whetten, S. Reif, R. Whetten, and L. K. Murphy-McMillan Trauma, Mental Health, Distrust, and Stigma Among HIV-Positive Persons: Implications for Effective Care
Psychosom Med,
June 1, 2008;
70(5):
531 - 538.
[Abstract][Full Text][PDF]
S. Willard and A. Angelino The Need for Sociocultural Awareness to Maximize Treatment Acceptance and Adherence in Individuals Initiating HIV Therapy
J Int Assoc Physicians AIDS Care (Chic Ill),
March 1, 2008;
7(1_suppl):
S17 - S21.
[Abstract][PDF]
J. K. Burke-Miller, J. A. Cook, M. H. Cohen, N. A. Hessol, T. E. Wilson, J. L. Richardson, P. Williams, and S. J. Gange Longitudinal Relationships Between Use of Highly Active Antiretroviral Therapy and Satisfaction With Care Among Women Living With HIV/AIDS
Am J Public Health,
June 1, 2006;
96(6):
1044 - 1051.
[Abstract][Full Text][PDF]
M. C. Bacon, V. von Wyl, C. Alden, G. Sharp, E. Robison, N. Hessol, S. Gange, Y. Barranday, S. Holman, K. Weber, et al. The Women's Interagency HIV Study: an Observational Cohort Brings Clinical Sciences to the Bench
Clin. Vaccine Immunol.,
September 1, 2005;
12(9):
1013 - 1019.
[Full Text][PDF]